The nurse is concerned that a client prescribed octreotide (Sandostatin) is at risk for drug ...

Correct Answer: 1,2,3,4
Rationale 1: Concurrent administration with antidiabetic agents or insulin can produce hypoglycemia.
Rationale 2: Concurrent administration with a beta blocker can cause additive bradycardia.
Rationale 3: Concurrent administration with a calcium channel blocker can cause additive bradycardia.
Rationale 4: Concurrent administration with an antidiarrheal can lead to severe constipation, intestinal obstruction, or paralytic ileus.
Rationale 5: This medication does not interact with antibiotics.
Global Rationale: Concurrent administration with antidiabetic agents or insulin can produce hypoglycemia. Concurrent administration with a beta blocker or calcium channel blocker can cause additive bradycardia. Concurrent administration with an antidiarrheal can lead to severe constipation, intestinal obstruction, or paralytic ileus. This medication does not interact with antibiotics.

What an excellent community, thanks for answering